Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH)

Q: What does CUSIP 30050B101 represent in this 13F holders report?

CUSIP 30050B101 is the security identifier for EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share used to aggregate holder disclosures.

Q: How many institutions held EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in Q2 2017?

163 institutional investors reported EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share for Q2 2017. Use the holders table for investor-level position and value details.

CUSIP: 30050B101

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class: Equity / Class A Common Stock, par value $0.01 per share
Shares outstanding: 112,318,617
Total 13F shares: 61,976,434
Share change: +20,313,157
Total reported value: $1,571,057,213
Put/Call ratio: 71%
Price per share: $25.35
Number of holders: 163
Value change: +$516,654,926
Number of buys: 111
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 30050B101?
CUSIP 30050B101 identifies EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2017
Previous quarter: Q1 2017

Recent filing periods for CUSIP 30050B101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
JPMORGAN CHASE & CO	13F	Company	4.5%	5,058,941	$112,815,000	—	31 Mar 2017	13F
FMR LLC	13F	Company	4%	4,531,523	$101,053,000	—	31 Mar 2017	13F
Pennant Capital Management, LLC	13F	Company	2.5%	2,843,021	$63,399,000	—	31 Mar 2017	13F
VANGUARD GROUP INC	13F	Company	2.3%	2,531,928	$56,462,000	—	31 Mar 2017	13F
Invesco Ltd.	13F	Company	2%	2,265,734	$50,526,000	—	31 Mar 2017	13F
BLAIR WILLIAM & CO/IL	13F	Company	1.5%	1,662,021	$32,742,000	—	31 Mar 2017	13F
PERCEPTIVE ADVISORS LLC	13F	Company	1.3%	1,444,500	$32,212,000	—	31 Mar 2017	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.2%	1,399,937	$31,219,000	—	31 Mar 2017	13F
TPG Group Holdings (SBS) Advisors, Inc.	13F	Company	1.2%	1,313,038	$29,281,000	—	31 Mar 2017	13F
TimesSquare Capital Management, LLC	13F	Company	1.2%	1,310,000	$29,213,000	—	31 Mar 2017	13F
BlackRock Finance, Inc.	13F	Company	0.94%	1,060,859	$23,658,000	—	31 Mar 2017	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.98%	1,099,600	$22,872,000	—	31 Mar 2017	13F
Elk Creek Partners, LLC	13F	Company	0.88%	988,860	$22,052,000	—	31 Mar 2017	13F
WADDELL & REED FINANCIAL INC	13F	Company	0.83%	933,287	$20,812,000	—	31 Mar 2017	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.74%	835,437	$18,630,000	—	31 Mar 2017	13F
MACKENZIE FINANCIAL CORP	13F	Company	0.66%	741,742	$16,541,000	—	31 Mar 2017	13F
OppenheimerFunds, Inc.	13F	Company	0.66%	738,075	$16,459,000	—	31 Mar 2017	13F
Marshall Wace North America L.P.	13F	Company	0.65%	733,762	$16,143,000	—	31 Mar 2017	13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	13F	Company	0.53%	600,562	$13,392,533	—	31 Mar 2017	13F
Casdin Capital, LLC	13F	Company	0.46%	520,000	$11,596,000	—	31 Mar 2017	13F
COLUMBIA WANGER ASSET MANAGEMENT LLC	13F	Company	0.44%	491,361	$10,957,000	—	31 Mar 2017	13F
PFM Health Sciences, LP	13F	Company	0.43%	480,422	$10,713,000	—	31 Mar 2017	13F
EDMOND DE ROTHSCHILD HOLDING S.A.	13F	Company	0.32%	362,000	$8,073,000	—	31 Mar 2017	13F
Granahan Investment Management, LLC	13F	Company	0.32%	355,459	$7,927,000	—	31 Mar 2017	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.32%	354,440	$7,904,000	—	31 Mar 2017	13F
CITADEL ADVISORS LLC	13F	Company	0.31%	353,239	$7,877,000	—	31 Mar 2017	13F
Tygh Capital Management, Inc.	13F	Company	0.28%	314,942	$7,023,000	—	31 Mar 2017	13F
NEXT CENTURY GROWTH INVESTORS LLC	13F	Company	0.28%	314,200	$7,006,000	—	31 Mar 2017	13F
DEUTSCHE BANK AG\	13F	Company	0.25%	280,609	$6,256,000	—	31 Mar 2017	13F
STATE STREET CORP	13F	Company	0.25%	280,190	$6,249,000	—	31 Mar 2017	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.23%	261,566	$5,833,000	—	31 Mar 2017	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.21%	236,080	$5,264,000	—	31 Mar 2017	13F
NORTHERN TRUST CORP	13F	Company	0.2%	220,034	$4,906,000	—	31 Mar 2017	13F
FRIESS ASSOCIATES LLC	13F	Company	0.19%	210,000	$4,683,000	—	31 Mar 2017	13F
SYSTEMATIC FINANCIAL MANAGEMENT LP	13F	Company	0.17%	188,605	$4,206,000	—	31 Mar 2017	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.16%	183,741	$4,097,000	—	31 Mar 2017	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.16%	178,511	$3,981,000	—	31 Mar 2017	13F
Russell Investments Group, Ltd.	13F	Company	0.15%	168,409	$3,755,000	—	31 Mar 2017	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.14%	162,116	$3,615,000	—	31 Mar 2017	13F
Timpani Capital Management LLC	13F	Company	0.14%	160,939	$3,589,000	—	31 Mar 2017	13F
OSTERWEIS CAPITAL MANAGEMENT INC	13F	Company	0.14%	154,345	$3,442,000	—	31 Mar 2017	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.13%	150,000	$3,345,000	—	31 Mar 2017	13F
Alyeska Investment Group, L.P.	13F	Company	0.12%	136,700	$3,048,000	—	31 Mar 2017	13F
Bank of New York Mellon Corp	13F	Company	0.12%	135,891	$3,030,000	—	31 Mar 2017	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.12%	130,053	$2,900,000	—	31 Mar 2017	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.11%	118,867	$2,651,000	—	31 Mar 2017	13F
DOWLING & YAHNKE LLC	13F	Company	0.1%	116,350	$2,595,000	—	31 Mar 2017	13F
MORGAN STANLEY	13F	Company	0.1%	107,557	$2,399,000	—	31 Mar 2017	13F
BlueCrest Capital Management Ltd	13F	Company	0.09%	101,291	$2,259,000	—	31 Mar 2017	13F
GABELLI FUNDS LLC	13F	Company	0.09%	100,000	$2,230,000	—	31 Mar 2017	13F

Institutional Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q2 2017

As of 30 Jun 2017, Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) was held by 163 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 61,976,434 shares. The largest 10 holders included FMR LLC, JPMORGAN CHASE & CO, VANGUARD GROUP INC, BlackRock Inc., RIVERBRIDGE PARTNERS LLC, Invesco Ltd., Pennant Capital Management, LLC, BLAIR WILLIAM & CO/IL, COLUMBIA WANGER ASSET MANAGEMENT LLC, and MILLENNIUM MANAGEMENT LLC. This page lists 163 institutional shareholders reporting positions in this security for the Q2 2017 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2017 vs Q1 2017 Across Filers

Q1 2017 holders

131

Q2 2017 holders

163

Holder diff

Investor	Q1 2017 Shares	Q2 2017 Shares	Share Diff	Share Chg %	Q1 2017 Value $	Q2 2017 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.